Copyright Reports & Markets. All rights reserved.

Global Immunohematology Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Immunohematology by Type
    • 1.3.1 Overview: Global Immunohematology Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Immunohematology Consumption Value Market Share by Type in 2025
    • 1.3.3 Immunohematology Analyzers and Systems
    • 1.3.4 Immunohematology Reagent
  • 1.4 Classification of Immunohematology by Downstream Customers
    • 1.4.1 Overview: Global Immunohematology Market Size by Downstream Customers: 2021 Versus 2025 Versus 2032
    • 1.4.2 Global Immunohematology Consumption Value Market Share by Downstream Customers in 2025
    • 1.4.3 Hospital Transfusion Department/Blood Bank
    • 1.4.4 Blood Center/Blood Collection and Supply Institution
    • 1.4.5 Reference Laboratory/Transplant Center
    • 1.4.6 Others
  • 1.5 Classification of Immunohematology by Clinical Complexity
    • 1.5.1 Overview: Global Immunohematology Market Size by Clinical Complexity: 2021 Versus 2025 Versus 2032
    • 1.5.2 Global Immunohematology Consumption Value Market Share by Clinical Complexity in 2025
    • 1.5.3 Conventional High Frequency
    • 1.5.4 High Complexity/High Added Value
  • 1.6 Global Immunohematology Market by Application
    • 1.6.1 Overview: Global Immunohematology Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Blood-Related Diseases
    • 1.6.3 HIV
    • 1.6.4 Hepatitis
  • 1.7 Global Immunohematology Market Size & Forecast
  • 1.8 Global Immunohematology Market Size and Forecast by Region
    • 1.8.1 Global Immunohematology Market Size by Region: 2021 VS 2025 VS 2032
    • 1.8.2 Global Immunohematology Market Size by Region, (2021-2032)
    • 1.8.3 North America Immunohematology Market Size and Prospect (2021-2032)
    • 1.8.4 Europe Immunohematology Market Size and Prospect (2021-2032)
    • 1.8.5 Asia-Pacific Immunohematology Market Size and Prospect (2021-2032)
    • 1.8.6 South America Immunohematology Market Size and Prospect (2021-2032)
    • 1.8.7 Middle East & Africa Immunohematology Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Bio-Rad Laboratories
    • 2.1.1 Bio-Rad Laboratories Details
    • 2.1.2 Bio-Rad Laboratories Major Business
    • 2.1.3 Bio-Rad Laboratories Immunohematology Product and Solutions
    • 2.1.4 Bio-Rad Laboratories Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Bio-Rad Laboratories Recent Developments and Future Plans
  • 2.2 Grifols
    • 2.2.1 Grifols Details
    • 2.2.2 Grifols Major Business
    • 2.2.3 Grifols Immunohematology Product and Solutions
    • 2.2.4 Grifols Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Grifols Recent Developments and Future Plans
  • 2.3 Immucor (Werfen)
    • 2.3.1 Immucor (Werfen) Details
    • 2.3.2 Immucor (Werfen) Major Business
    • 2.3.3 Immucor (Werfen) Immunohematology Product and Solutions
    • 2.3.4 Immucor (Werfen) Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Immucor (Werfen) Recent Developments and Future Plans
  • 2.4 QuidelOrtho
    • 2.4.1 QuidelOrtho Details
    • 2.4.2 QuidelOrtho Major Business
    • 2.4.3 QuidelOrtho Immunohematology Product and Solutions
    • 2.4.4 QuidelOrtho Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 QuidelOrtho Recent Developments and Future Plans
  • 2.5 Beckman Coulter
    • 2.5.1 Beckman Coulter Details
    • 2.5.2 Beckman Coulter Major Business
    • 2.5.3 Beckman Coulter Immunohematology Product and Solutions
    • 2.5.4 Beckman Coulter Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Beckman Coulter Recent Developments and Future Plans
  • 2.6 DIAGAST
    • 2.6.1 DIAGAST Details
    • 2.6.2 DIAGAST Major Business
    • 2.6.3 DIAGAST Immunohematology Product and Solutions
    • 2.6.4 DIAGAST Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 DIAGAST Recent Developments and Future Plans
  • 2.7 Hemo bioscience
    • 2.7.1 Hemo bioscience Details
    • 2.7.2 Hemo bioscience Major Business
    • 2.7.3 Hemo bioscience Immunohematology Product and Solutions
    • 2.7.4 Hemo bioscience Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Hemo bioscience Recent Developments and Future Plans
  • 2.8 Institut de Biotechnologies Jacques Boy
    • 2.8.1 Institut de Biotechnologies Jacques Boy Details
    • 2.8.2 Institut de Biotechnologies Jacques Boy Major Business
    • 2.8.3 Institut de Biotechnologies Jacques Boy Immunohematology Product and Solutions
    • 2.8.4 Institut de Biotechnologies Jacques Boy Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Institut de Biotechnologies Jacques Boy Recent Developments and Future Plans
  • 2.9 MTC INVITRO
    • 2.9.1 MTC INVITRO Details
    • 2.9.2 MTC INVITRO Major Business
    • 2.9.3 MTC INVITRO Immunohematology Product and Solutions
    • 2.9.4 MTC INVITRO Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 MTC INVITRO Recent Developments and Future Plans
  • 2.10 AliveDx
    • 2.10.1 AliveDx Details
    • 2.10.2 AliveDx Major Business
    • 2.10.3 AliveDx Immunohematology Product and Solutions
    • 2.10.4 AliveDx Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 AliveDx Recent Developments and Future Plans
  • 2.11 AI KANG
    • 2.11.1 AI KANG Details
    • 2.11.2 AI KANG Major Business
    • 2.11.3 AI KANG Immunohematology Product and Solutions
    • 2.11.4 AI KANG Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 AI KANG Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Immunohematology Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Immunohematology by Company Revenue
    • 3.2.2 Top 3 Immunohematology Players Market Share in 2025
    • 3.2.3 Top 6 Immunohematology Players Market Share in 2025
  • 3.3 Immunohematology Market: Overall Company Footprint Analysis
    • 3.3.1 Immunohematology Market: Region Footprint
    • 3.3.2 Immunohematology Market: Company Product Type Footprint
    • 3.3.3 Immunohematology Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Immunohematology Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Immunohematology Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Immunohematology Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Immunohematology Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Immunohematology Consumption Value by Type (2021-2032)
  • 6.2 North America Immunohematology Market Size by Application (2021-2032)
  • 6.3 North America Immunohematology Market Size by Country
    • 6.3.1 North America Immunohematology Consumption Value by Country (2021-2032)
    • 6.3.2 United States Immunohematology Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Immunohematology Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Immunohematology Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Immunohematology Consumption Value by Type (2021-2032)
  • 7.2 Europe Immunohematology Consumption Value by Application (2021-2032)
  • 7.3 Europe Immunohematology Market Size by Country
    • 7.3.1 Europe Immunohematology Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Immunohematology Market Size and Forecast (2021-2032)
    • 7.3.3 France Immunohematology Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Immunohematology Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Immunohematology Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Immunohematology Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Immunohematology Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Immunohematology Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Immunohematology Market Size by Region
    • 8.3.1 Asia-Pacific Immunohematology Consumption Value by Region (2021-2032)
    • 8.3.2 China Immunohematology Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Immunohematology Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Immunohematology Market Size and Forecast (2021-2032)
    • 8.3.5 India Immunohematology Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Immunohematology Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Immunohematology Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Immunohematology Consumption Value by Type (2021-2032)
  • 9.2 South America Immunohematology Consumption Value by Application (2021-2032)
  • 9.3 South America Immunohematology Market Size by Country
    • 9.3.1 South America Immunohematology Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Immunohematology Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Immunohematology Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Immunohematology Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Immunohematology Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Immunohematology Market Size by Country
    • 10.3.1 Middle East & Africa Immunohematology Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Immunohematology Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Immunohematology Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Immunohematology Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Immunohematology Market Drivers
  • 11.2 Immunohematology Market Restraints
  • 11.3 Immunohematology Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Immunohematology Industry Chain
  • 12.2 Immunohematology Upstream Analysis
  • 12.3 Immunohematology Midstream Analysis
  • 12.4 Immunohematology Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Immunohematology market size was valued at US$ 2636 million in 2025 and is forecast to a readjusted size of US$ 3495 million by 2032 with a CAGR of 4.5% during review period.
    Commercially, immunohematology usually refers to pre-transfusion compatibility testing and blood-group serology/molecular typing solutions. The core menu includes ABO/Rh typing, antibody screening, antibody identification, crossmatching, DAT/IAT, antigen typing/extended phenotyping, and selected molecular typing for rare or complex cases. Product formats span gel/cards, reagent red cells, antisera, QC materials, fully/semi-automated analyzers, data-management software, and in some cases reference-laboratory testing services. Upstream inputs include antibodies, reagent RBC materials, plastics/consumables, automation modules, and software; midstream is reagent–instrument system integration; downstream customers are primarily hospital transfusion laboratories/blood banks, independent labs, blood centers, and reference labs.
    Immunohematology, as a core interdisciplinary field integrating immunology and hematology, focuses on the interaction between blood components and the immune system, covering key areas such as blood grouping, transfusion safety, diagnosis and treatment of autoimmune hematological diseases, and hematopoietic stem cell transplantation matching. It is an important part of the global healthcare system, and its development is closely linked to multiple global trends, including the upgrading of clinical needs, breakthroughs in technological innovation, and the protection of public health security. The continuous growth of global clinical transfusion demand and the continuous improvement of transfusion safety standards are the core driving forces. The demand for safe blood transfusion in various surgeries, chronic diseases and trauma treatment has promoted the transformation of immunohematology technology towards precision and standardization, reducing the risk of transfusion adverse reactions. The clinical diagnosis and treatment needs of hematological tumors, autoimmune hematological diseases and other diseases have promoted the discipline to extend towards precise immunotherapy and personalized diagnosis and treatment, broadening the research and application boundaries. Technological innovation continues to empower the industry. The application of automated detection platforms, molecular typing technologies, AI-assisted interpretation systems and other technologies has improved detection efficiency and accuracy, promoting the discipline to develop in a diversified and cross-integrated direction. The improvement of the global public health system and the enhancement of blood safety awareness have promoted countries to strengthen blood screening, rare blood type bank construction and standardized construction of immunohematology laboratories. At the same time, the upgrading of medical infrastructure in emerging markets has released new growth for the development of the discipline. The global cooperation between leading enterprises and scientific research institutions has accelerated the global popularization of technological achievements.
    Despite the continuous development of the global immunohematology field and the increasing clinical value, it still faces many challenges. High-end technologies and core reagent barriers are strict. The core technologies of precise molecular typing, high-end detection equipment and key reagents are monopolized by a few international leading enterprises. Emerging markets and developing countries have insufficient investment in scientific research, making it difficult to achieve technological breakthroughs and independent substitution, resulting in unbalanced distribution of medical resources. There are regional differences in the development of the discipline. Developed countries, relying on mature medical systems and scientific research strength, focus on cutting-edge technology research and development and clinical application, occupying a dominant position in the industry. However, some developing countries, limited by medical resources and professional talents, have insufficient accessibility of immunohematology detection and diagnosis and treatment services. There is a gap between clinical application and technological transformation. Some cutting-edge technologies have high R&D costs and long certification cycles, making it difficult to quickly land and popularize. At the same time, the shortage of professional and technical talents restricts the promotion and application of disciplinary technologies. In addition, there are regional differences in global industry standards and regulatory norms. Different countries have different requirements for detection processes, reagent certification and quality control, increasing the difficulty of cross-border promotion of technologies and products. Coupled with the safety and ethical controversies of some technologies, the balanced and high-quality development of global immunohematology is further restricted.
    This report is a detailed and comprehensive analysis for global Immunohematology market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Immunohematology market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Immunohematology market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Immunohematology market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Immunohematology market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Immunohematology
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Immunohematology market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bio-Rad Laboratories, Grifols, Immucor (Werfen), QuidelOrtho, Beckman Coulter, DIAGAST, Hemo bioscience, Institut de Biotechnologies Jacques Boy, MTC INVITRO, AliveDx, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Immunohematology market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Immunohematology Analyzers and Systems
    Immunohematology Reagent
    Market segment by Downstream Customers
    Hospital Transfusion Department/Blood Bank
    Blood Center/Blood Collection and Supply Institution
    Reference Laboratory/Transplant Center
    Others
    Market segment by Clinical Complexity
    Conventional High Frequency
    High Complexity/High Added Value
    Market segment by Application
    Blood-Related Diseases
    HIV
    Hepatitis
    Market segment by players, this report covers
    Bio-Rad Laboratories
    Grifols
    Immucor (Werfen)
    QuidelOrtho
    Beckman Coulter
    DIAGAST
    Hemo bioscience
    Institut de Biotechnologies Jacques Boy
    MTC INVITRO
    AliveDx
    AI KANG
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Immunohematology product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Immunohematology, with revenue, gross margin, and global market share of Immunohematology from 2021 to 2026.
    Chapter 3, the Immunohematology competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Immunohematology market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Immunohematology.
    Chapter 13, to describe Immunohematology research findings and conclusion.

    Buy now